{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:39:42Z","timestamp":1793425182949,"version":"4.5.0"},"reference-count":38,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2025,12,9]]},"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1136\/ejhpharm-2025-004732","type":"journal-article","created":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T18:20:16Z","timestamp":1766341216000},"page":"561-566","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["ICU Y-site compatibility at standardised infusion concentrations: method-stratified synthesis and practical chart"],"prefix":"10.1136","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4635-5785","authenticated-orcid":false,"given":"Gemma","family":"Garreta Fontelles","sequence":"first","affiliation":[{"name":"Pharmacy Department, Hospital Universitario Son Espases, Palma, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Padilla Casta\u00f1o","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hospital Universitario Son Espases, Palma, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Lopez Lopez-Cepero","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hospital Universitario Son Espases, Palma, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Maqueda Palau","sequence":"additional","affiliation":[{"name":"Nursing\u2014Intensive Care Medicine (ICU), Hospital Universitario Son Espases, Palma, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria del Carmen","family":"Barbado Monge","sequence":"additional","affiliation":[{"name":"Nursing supervisor\u2014Intensive Care Medicine (ICU), Hospital Universitario Son Espases, Palma, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Liron Sanchez","sequence":"additional","affiliation":[{"name":"Nursing supervisor\u2014Intensive Care Medicine (ICU), Hospital Universitario Son Espases, Palma, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Martorell Puigserver","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hospital Universitario Son Espases, Palma, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,12,21]]},"reference":[{"key":"2026102302151100000_33.6.561.1","first-page":"151","article-title":"Nature of Precipitation Resulted from Intravenous Drugs Incompatibility","volume":"4","author":"Hanifah","year":"2025","journal-title":"ASEAN Journal for Science and Engineering in Materials"},{"key":"2026102302151100000_33.6.561.2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.farma.2022.11.007","article-title":"Cross-sectional study of potential incompatibility of intravenous medications in a neonatal intensive care unit in Indonesia","volume":"47","author":"Mahendra","year":"2023","journal-title":"Farm Hosp"},{"key":"2026102302151100000_33.6.561.3","first-page":"171","article-title":"Mapping of incompatibility assay: bringing method to problem in critical care","volume":"6","author":"Hanifah","year":"2014","journal-title":"Int J Pharm Pharmaceut Sci"},{"key":"2026102302151100000_33.6.561.4","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2014-000539"},{"key":"2026102302151100000_33.6.561.5","doi-asserted-by":"crossref","first-page":"20220002","DOI":"10.1515\/pthp-2022-0002","article-title":"Y-site compatibility of intravenous medications commonly used in intensive care units: laboratory tests on 75 mixtures involving nine main drugs","volume":"7","author":"Ayari","year":"2022","journal-title":"Pharm Technol Hosp Pharm"},{"key":"2026102302151100000_33.6.561.6","doi-asserted-by":"crossref","DOI":"10.3390\/ph12020067","article-title":"Investigations of Physical Compatibilities of Commonly Used Intravenous Medications with and without Parenteral Nutrition in Pediatric Cardiovascular Intensive Care Unit Patients","volume":"12","author":"Greenhill","year":"2019","journal-title":"Pharmaceuticals (Basel)"},{"key":"2026102302151100000_33.6.561.7","doi-asserted-by":"publisher","DOI":"10.1177\/106002809603000303"},{"key":"2026102302151100000_33.6.561.8","unstructured":"ASHP Best Practices . Adult continuous infusions standards. standardize 4 safety initiative. American Society Hospital Pharmacy (ASHP); 2025."},{"key":"2026102302151100000_33.6.561.9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.medin.2018.08.004","article-title":"Compatibility of drugs administered as Y-site infusion in intensive care units: A systematic review","volume":"44","author":"Castells Lao","year":"2020","journal-title":"Med Intensiva (Engl Ed)"},{"key":"2026102302151100000_33.6.561.10","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181e8adcc"},{"key":"2026102302151100000_33.6.561.11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.18773\/austprescr.2008.057","article-title":"To mix or not to mix \u2013 compatibilities of parenteral drug solutions","volume":"31","author":"Murney","year":"2008","journal-title":"Aust Prescr"},{"key":"2026102302151100000_33.6.561.12","first-page":"1","article-title":"Hidden medication loss when using a primary administration set for small-volume intermittent infusions","volume":"25","year":"2020","journal-title":"ISMP Medication Safety Alert"},{"key":"2026102302151100000_33.6.561.13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/NAN.0000000000000355","article-title":"Best Practice for Delivering Small-Volume Intermittent Intravenous Infusions","volume":"43","author":"Harding","year":"2020","journal-title":"J Infus Nurs"},{"key":"2026102302151100000_33.6.561.14","unstructured":"NHS England . Unintended bolus of medication if infused at speed from residual space in giving set. 2023. Available: https:\/\/www.england.nhs.uk\/patient-safety\/patient-safety-insight\/learning-from-patient-safety-events\/how-we-acted-on-patient-safety-issues-you-recorded\/unintended-bolus-of-medication-if-infused-at-speed-from-residual-space-in-giving-set\/ [Accessed 02 Nov 2025]."},{"key":"2026102302151100000_33.6.561.15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4212\/cjhp.v65i1.1099","article-title":"Errors Associated with IV Infusions in Critical Care","volume":"65","author":"Summa-Sorgini","year":"2012","journal-title":"Can J Hosp Pharm"},{"key":"2026102302151100000_33.6.561.16","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-2452"},{"key":"2026102302151100000_33.6.561.17","unstructured":"Shekelle PG , Wachter RM , Pronovost PJ , et al . Making health care safer II: an updated critical analysis of the evidence for patient safety practices. Evid Rep Technol Assess (Full Rep) 2013;1\u2013945."},{"key":"2026102302151100000_33.6.561.18","unstructured":"American Society of Health-System Pharmacists . Best practices: position and guidance documents of ASHP. Bethesda, MD: American Society of Health-System Pharmacists (ASHP), 2014."},{"key":"2026102302151100000_33.6.561.19","first-page":"1117","article-title":"Visual compatibility of amiodarone hydrochloride with various antimicrobial agents during simulated Y-site injection","volume":"45","author":"Benedict","year":"1988","journal-title":"Am J Hosp Pharm"},{"key":"2026102302151100000_33.6.561.20","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/ajhp\/58.6.504","article-title":"Visual compatibility of amiodarone hydrochloride injection with various intravenous drugs","volume":"58","author":"Chalmers","year":"2001","journal-title":"Am J Health Syst Pharm"},{"key":"2026102302151100000_33.6.561.21","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp140165"},{"key":"2026102302151100000_33.6.561.22","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp050150"},{"key":"2026102302151100000_33.6.561.23","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1093\/ajhp\/54.15.1735","article-title":"Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration","volume":"54","author":"Trissel","year":"1997","journal-title":"Am J Health Syst Pharm"},{"key":"2026102302151100000_33.6.561.24","first-page":"311","article-title":"Compatibility screening of bivalirudin during simulated y-site administration with other drugs","volume":"6","author":"Trissel","year":"2002","journal-title":"Int J Pharm Compd"},{"key":"2026102302151100000_33.6.561.25","first-page":"630","article-title":"Visual compatibility of esmolol hydrochloride and various injectable drugs during simulated Y-site injection","volume":"45","author":"Colucci","year":"1988","journal-title":"Am J Hosp Pharm"},{"key":"2026102302151100000_33.6.561.26","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1093\/ajhp\/54.19.2192","article-title":"Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration","volume":"54","author":"Trissel","year":"1997","journal-title":"Am J Health Syst Pharm"},{"key":"2026102302151100000_33.6.561.27","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2016-001038"},{"key":"2026102302151100000_33.6.561.28","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/ajhp\/54.11.1287","article-title":"Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration","volume":"54","author":"Trissel","year":"1997","journal-title":"Am J Health Syst Pharm"},{"key":"2026102302151100000_33.6.561.29","doi-asserted-by":"publisher","DOI":"10.5114\/ait.2021.103542"},{"key":"2026102302151100000_33.6.561.30","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1213\/01.ANE.0000087802.50796.FB","article-title":"Physicochemical Compatibility of Propofol-Lidocaine Mixture","volume":"97","author":"Masaki","year":"2003","journal-title":"Anesthesia & Analgesia"},{"key":"2026102302151100000_33.6.561.31","first-page":"328","article-title":"Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures","volume":"20","author":"Foushee","year":"2016","journal-title":"Int J Pharm Compd"},{"key":"2026102302151100000_33.6.561.32","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/10600280231179999","article-title":"Physical and Chemical Compatibility of Medications Commonly Used in Critically Ill Patients With Balanced Crystalloids: A Systematic Review","volume":"58","author":"Buckley","year":"2024","journal-title":"Ann Pharmacother"},{"key":"2026102302151100000_33.6.561.33","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2014-000444"},{"key":"2026102302151100000_33.6.561.34","first-page":"146","article-title":"Compatibilit\u00e9 physique de m\u00e9dicaments administr\u00e9s dans l\u2019unit\u00e9 de soins intensifs","volume":"48","author":"Juan Perez","year":"2015","journal-title":"Pharmactuel"},{"key":"2026102302151100000_33.6.561.35","unstructured":"United States Pharmacopeia Convention . General chapter <797> pharmaceutical compounding\u2014Sterile preparations. In: United States Pharmacopeia (USP). USP 47\u2013NF 42. USP Convention, 2023."},{"key":"2026102302151100000_33.6.561.36","unstructured":"European Commission . EudraLex, Volume 4: good manufacturing practice guidelines. European Commission; 2022."},{"key":"2026102302151100000_33.6.561.37","doi-asserted-by":"crossref","first-page":"352","DOI":"10.5005\/jp-journals-10071-23756","article-title":"Phenytoin Sodium and Acetate-Maleate Buffered Balanced Salt Solutions are Physically Incompatible!","volume":"25","author":"Mahajan","year":"2021","journal-title":"Indian J Crit Care Med"},{"key":"2026102302151100000_33.6.561.38","first-page":"706","article-title":"Design and Implementation of an Analgesia, Sedation, and Paralysis Order Set to Enhance Compliance of pro re nata Medication Orders with Joint Commission Medication Management Standards in a Pediatric ICU","volume":"46","author":"Procaccini","year":"2020","journal-title":"Jt Comm J Qual Patient Saf"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2025-004732","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:16:02Z","timestamp":1792746962000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2025-004732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,21]]},"references-count":38,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,10,23]]},"published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1136\/ejhpharm-2025-004732"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2025-004732","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,21]]}}}